Intraoperative infusion of amino acids has been found to stimulate energy expenditure and thereby prevent anaesthesia-induced hypothermia. Rectal temperature and respiratory gas exchange were measured in 24 female patients before and after isoflurane anaesthesia. Sixteen patients had an amino acid mixture of 240 kJ h
Anaesthesia-induced hypothermia constitutes a clinical problem by causing impaired blood coagulation [1] , prolonged drug action [2] , negative postoperative nitrogen balance [3] and reduced resistance to surgical wound infections [4] . Consequently, several devices to combat hypothermia have been developed [5, 6] . Most of these are designed to minimize heat loss from the body surface. However, general anaesthesia does not induce hypothermia solely by interfering with regulation of heat dissipation. Most anaesthetics also reduce considerably heat generation by suppressing whole body oxidative metabolism [7] [8] [9] . Little attention has been paid to preventing the development of anaesthesia-induced hypothermia by stimulating the generation of heat.
It is well known from earlier studies that in the unanaesthetized state, administration of nutrients, especially protein and amino acid mixtures, stimulates resting energy expenditure (see [10] ). Moreover, approximately 60 % of the extra heat produced in response to amino acid administration accumulates, thus increasing the temperature of mixed venous blood [11] [12] [13] [14] . We recently found that the mechanisms for nutrient-induced thermogenesis are not impaired during general anaesthesia [15] . In contrast, the thermic effect of amino acids was found to be increased five-fold during, and most markedly, immediately after isoflurane-nitrous oxide anaesthesia. The enhanced amino acid-induced thermogenesis counteracted the anaesthesia-induced reduction in metabolism and prevented the development of hypothermia. However, amino acid infusions started at the onset of anaesthesia did not prevent the initial reduction in temperature that occurred within the first 20 min of anaesthesia [15] .
The present study was designed to see if starting or completing the amino acid infusion before the onset of anaesthesia would induce heat production, which would be more effective in reducing the initial decrease in temperature and thereby counteract the development of anaesthesia-induced hypothermia more effectively than intraoperative infusions. Therefore, patients admitted for elective surgery were given amino acid infusions over 1-2 h before induction of anaesthesia. Body temperature was measured before, during and after anaesthesia. Energy expenditure was measured before amino acid infusions, immediately before and soon after anaesthesia. The results were compared with those from a control patient group receiving nutrient-free saline solutions, and a group of healthy individuals not subjected to premedication or anaesthesia.
Patients and methods
We studied 24 female patients and six healthy women. The patients were undergoing hysterectomy because of menorrhagia and were otherwise healthy, receiving no medications (table 1) . Eight of the patients (group A) had amino acids infused i.v. for 1 h before anaesthesia and continuing throughout the first hour of anaesthesia. Eight patients (group B) had amino acids infused for 2 h before the onset of anaesthesia. Eight control patients (group C) had corresponding volumes of nutrient-free saline solution infused for 1 h before and the first hour of anaesthesia. The six healthy female volunteers (group D) not subjected to premedication or anaesthesia, reported to the laboratory after an overnight fast. They were studied before and over the 4 h after the onset of a 2-h amino acid infusion, identical to that given to the patients (groups A and B). All subjects were informed of the nature, purpose and possible risks of the study before giving consent to participate. The study was reviewed and approved by the institutional Ethics Committee.
The first 16 patients studied were allocated to groups A and C. Otherwise the patients were not randomized. The study was not blinded. Patients in group B, receiving the entire 2-h infusion of amino acids before the onset of anaesthesia were studied later, as was the volunteer group. All patients were prepared according to standard preoperative routines. All studies, including those in the volunteers, were started at 07:30 after an overnight fast of 12-14 h. At 3 h before anaesthesia the patients received oral premedication with lorazepam 1-2 mg. In the patients and volunteers, a thermometer probe was inserted in the rectum 10-15 cm and two arm veins were cannulated. One catheter for amino acid infusion was inserted and advanced centrally, 30 cm, to reach the subclavian vein. A cubital vein of the other arm was cannulated for blood sampling. Except for 1 u. of warmed blood, given to one of the controls during anaesthesia, no warming device was used. The nutrient-free saline infusions (500 ml h 91 ) were given at room temperature to all patients during operation.
Respiratory gas exchange was measured for 6-10-min periods by continuous breath-by-breath analysis (Medigraphics, System CPX/D, Medical Graphics Corp., St Paul, MN 55127, USA) using a noseclip and mouthpiece technique with which the subjects had been previously familiarized. The apparatus used for gas exchange analysis, periodically controlled in the laboratory for gas flow and gas concentrations, was calibrated for gas flow and concentrations using a 3 litre precision syringe and calibrated gases before each study. During periods of gas collection, the gas flow and concentrations were measured continuously and gas exchange automatically calculated and recorded each 20 s. Frequent recording facilitates immediate detection of a gas leakage, which may occur, especially when collecting expired gas in the early postoperative period.
Before the amino acid or saline infusions were started, baseline measurements were made of temperature, heart rate, arterial pressure and pulmonary gas exchange. Rectal temperature was measured each 1 min, either digitally, as described earlier [16] , or with an Exagon thermometer (MC 8700, Roskilde, Denmark) throughout the observation period, that is before, during and after anaesthesia until 4 h after the end of the amino acid infusion for the patients; and before, during and 2 h after the amino acid infusion for the volunteers. After each study, the probes were calibrated with the same precision thermometer. Room temperature was monitored continuously and maintained at 21-23 ЊC. Blood samples for analysis of free plasma amino acids were obtained twice, at the end of the amino acid-saline infusion and 2 h later.
During recovery from anaesthesia, patients were observed by the same observer for the presence or absence of obvious generalized shivering. Postoperative pain relief was given to all patients after measurement of gas exchange after operation. In Group A, after baseline measurements at 1 h after premedication, a mixture of 19 amino acids (Vamin 18 g N/ litre, Pharmacia, Sweden) was infused i.v. at a rate of 126 ml h 91 , corresponding to 240 kJ of energy per hour over 2 h. After 60 min of infusion, measurements of pulmonary gas exchange were repeated ("before anaesthesia"), and immediately after that, the patients were anaesthetized. The amino acid infusion then continued during the first hour of anaesthesia. Within 5 min after emergence from anaesthesia, analysis of pulmonary gas exchange was repeated ("after anaesthesia"). Mean duration of anaesthesia in group A was 144 (SEM 9) min and that of surgery 90 (7) min. In group B, patients received an amino acid infusion, identical to that given in group A. However, it was given 2 h before anaesthesia. When the amino acid infusion ceased, measurements of pulmonary gas exchange were repeated ("before anaesthesia"), after which anaesthesia was induced. Within 5 min after the end of anaesthesia, analysis of pulmonary gas exchange was repeated ("after anaesthesia"). In group B, mean duration of anaesthesia was 128 (13) min and that of surgery 88 (12) min. In group C, control patients were treated in the same manner as group A, but they received equal volumes of nutrient-free Ringer's solution instead of amino acids for 1 h before anaesthesia and during the first hour of anaesthesia. Pulmonary gas exchange measurements were performed and repeated as in group A. In group C the duration of anaesthesia was 154 (11) min and that of surgery 99 (7) min. Differences in duration of anaesthesia and surgery represent the time necessary for the routine procedures of anaesthesia and pre-surgical preparation of the patients. In group D, healthy volunteers were studied in the morning after an overnight fast and 30 min rest in the laboratory. After baseline measurements they received a 2-h amino acid infusion , was identical to that given during operation in our earlier study of anaesthetized patients [15] .
Anaesthesia was the same in all patients and comprised induction with thiopentone 5 mg kg 91 and maintenance with 1-2 % enflurane and 60 % nitrous oxide in oxygen using an Engström ventilator 2000 (Gambro Engström AB, Bromma, Sweden). All patients were monitored with pulse oximetry and capnography (Datex, Sweden). Neuromuscular block, monitored by a train-of-four technique [17] , was produced with a bolus dose of atracurium 0.5 mg kg 91 followed by a continuous infusion of 0.5 mg kg 91 h
91
. Fentanyl 3 g kg 91 was given before surgery. Atracurium infusion was terminated 0.5 h before the expected end of operation, and residual neuromuscular block was antagonized with neostigmine 2.5 mg together with atropine 0.5 mg immediately after the end of surgery. Heart rate was recorded from the electrocardiogram and arterial pressure determined by sphygmomanometry at 5-min intervals.
Energy expenditure was calculated from pulmonary gas exchange [18, 19] . Free plasma amino acids were separated by high-pressure liquid chromatography and analysed fluorimetrically using a fluorescence HPLC monitor (RF-535, Shimadzu, Tokyo, Japan). Standard statistical methods were used. For comparison between groups, data were first analysed by repeated measures ANOVA and differences then calculated by post hoc testing [20] . Within-group differences between baseline and later measurements were calculated using the t test for paired observations. Data in the text, tables and figures are given as mean (SEM).
Results

RECTAL TEMPERATURE
Baseline rectal temperatures were 36.88 (0.07) ЊC in patient groups A-C and 36.65 (0.10) ЊC in the volunteer group D (ns) (tables 2, 3). During the first hour of amino acid infusion, rectal temperature increased significantly from the basal state, by 0.20 (0.04) ЊC (P : 0.001) in the volunteers and by 0.23 (0.07) ЊC and 0.38 (0.09) ЊC in patient groups A and B, respectively (tables 2, 3, figs 1, 2). In control patients (group C), it did not change during the 1-h pre-anaesthesia infusion of saline. After 2 h of amino acid infusion, the temperature increase was 0.35 (0.04) ЊC in volunteers and 0.60 (0.09) ЊC in group B (P : 0.05) (tables 2, 3, fig. 3 ). Onset of anaesthesia caused immediate temperature reductions in all patients. During the first 30 min of anaesthesia, it decreased by 0.34 (0.04) ЊC in group A, 0.48 (0.10) ЊC in group B and 0.44 (0.07) ЊC in control patients (group C) ( fig. 1) . In group B, receiving the entire amino acid infusion before anaesthesia the initial decrease in rectal temperature closely followed that of the controls, with a steep reduction of 0.94 (0.16) ЊC during the first hour of anaesthesia ( fig. 1 ). However, the decrease in temperature from the onset of anaesthesia was significantly greater in the control group than in both the amino acid treated groups throughout anaesthesia. At awakening after 144 (9) and 128 (13) min of anaesthesia in groups A and B, respectively, the temperature decline had not reduced the temperatures to levels significantly below baseline values. When the control patients awakened after 154 (11) min of anaesthesia, mean temperature was 1.00 (0.08) ЊC below the baseline level (P : 0.01) (table 3, fig. 2 ). This group required approximately 100 min in postoperative recovery to return to baseline temperature levels ( fig. 2 ). In the volunteers, not subjected to premedication or anaesthesia, rectal temperature increased by 0.35 (0.04) ЊC during infusion and continued to increase for 90 min after the amino acid infusion ceased and remained at its maximum when the study ended (table 2, fig. 3 ).
PULMONARY OXYGEN UPTAKE
Baseline oxygen consumption did not differ significantly between the patient groups ( ) did not differ from those in the Table 3 Rectal temperature, pulmonary oxygen uptake, respiratory exchange ratio, energy expenditure, pulmonary ventilation and heart rate measured 1 h after premedication ("baseline"), during amino acid-saline infusion before the onset of anaesthesia (before anaesthesia) and on awakening (after anaesthesia) (mean (SEM)). Group A : eight patients receiving amino acids for 1 h before the onset of anaesthesia and 1 h of anaesthesia; group B : eight patients receiving amino acids for 2 h before the onset of anaesthesia; and group C : eight control patients receiving saline solution for 1 h before the onset of anaesthesia and for 1 h of anaesthesia. amino acid treated groups (A and B). After 1 h of preoperative amino acid infusion, pulmonary oxygen uptake had increased by 34 (12) ml min 91 in group A, and by 38 (3) ml min 91 in the volunteers (group D) (ns). After 2 h of preoperative amino acid infusion, oxygen uptake had increased by 34 (6) ml min 91 in group B, which was not different from that in group D (39 (5) ml min 91 ) (tables 2, 3). In the controls (group C), oxygen uptake did not change from its baseline level during the 1-h preanaesthesia saline infusion (table 3) .
At awakening, oxygen uptake increased to 85 (15) ml min 91 (P : 0.001) and 102 (45) ml min
91
(P : 0.05) above baseline in groups A and B, respectively. In group C, oxygen uptake did not significantly exceed baseline at awakening (table 3) . In the volunteer group D, maximum oxygen consumption was observed when the amino acid infusion ceased, and after that it decreased continuously. At 2 h after the end of infusion, it was still 21 (4) ml min 91 higher than in the basal state (P : 0.01) (table 2).
RESPIRATORY EXCHANGE RATIO
Baseline respiratory exchange ratio did not differ significantly between groups (tables 2, 3). In groups A and B the amino acids caused small but significant increases of 0.03 (0.01) (P : 0.05) and 0.04 (0.01) (P : 0.05), respectively. In the controls, no changes occurred. At awakening, there were no significant differences between patient groups (table 3). In volunteers, the respiratory exchange ratio did not change significantly during the amino acid infusion. However, it decreased gradually after the amino acid infusion ceased and at the end of the study was significantly lower than in the basal state (table 2) .
ENERGY EXPENDITURE
Energy expenditures measured at 1 h after premedication were significantly below basal values, calculated from body dimensions and age [21] in all the patients (table 1). The differences were 99.5 (2)% (P : 0.01) in group A, 911.5 (4)% (P : 0.05) in group B and 915 (3)% (P : 0.01) in group C. In the untreated volunteers (group D), basal energy expenditure did not differ significantly from calculated basal values (table 2) . As the changes in respiratory exchange ratio were relatively small, the changes in total energy expenditure closely followed those of pulmonary oxygen uptake. In group A it increased by 13 (4) W during 1 h of amino acid infusion, and in group B the increase after 2 h of infusion was 12 (2) W. In the control patients, energy expenditure remained essentially unchanged throughout the observation period (table 3). In the volunteers it increased during the 2-h amino acid infusion by 14 (1) W and remained significantly higher than the baseline measurements at 2 h after infusion (table 2) . At awakening from anaesthesia, energy expenditure increased significantly to 88 (6) and 94 (15) (table 3) . During the 1-h amino acid infusion before anaesthesia, it increased by 0.8 (0.2) litre min 91 in group A (P : 0.05). In group B, 2 h of pre-anaesthesia amino acid infusion increased ventilation by 0.7 (0.2) litre min 91 (P : 0.05). In the control patients, pulmonary ventilation did not change from baseline. At awakening, ventilation increased significantly by approximately 37 % and 49 % in groups and B, respectively. In the control patients, ventilation was unchanged at awakening (table 3) .
HEART RATE AND ARTERIAL OXYGEN SATURATION At emergence from anaesthesia, heart rate significantly exceeded baseline levels in groups A and C. In the volunteers, heart rate was slightly but significantly higher than basal levels during and after amino acid infusion. Arterial oxygen saturation was unchanged during the study in all patients, being consistently 97-99 %.
SHIVERING
Shivering occurred at awakening after anaesthesia in all control patients, but in none of the patients in group A. In group B, two patients shivered after anaesthesia.
PLASMA CONCENTRATION OF FREE AMINO ACIDS
The control patients (group C) had normal plasma concentrations for the 21 amino acids analysed [22] after 1 h of anaesthesia, and also 2 h later. In groups (table 4) . In group B, premedicated, and receiving the entire infusion before the onset of anaesthesia, there was a significantly lower maximum sum of amino acid concentrations than the two other amino acid treated groups (A and D) (P : 0.05). This difference resulted from significantly reduced concentrations of the individual amino acids, glutamate, arginine, methionine, isoleucine and leucine. Glutamine tended to be higher only in group B compared with the other amino acid treated groups, and remained so 2 h after infusion. Immediately after infusion, the concentration of taurine was significantly higher in group A than in all of the other groups.
At 2 h after the amino acid infusions, individual amino acid concentrations were essentially similar in groups A, B and D, and only moderately increased compared with those in the control patients (group C). The sums of the amino acid concentrations were 2.39, 2.72, 2.31 and 3.17 mmol litre 91 in groups A, B, C and D, respectively (ns).
Discussion
Recently, we demonstrated that the thermic effect of amino acids is augmented during general anaesthesia, and that peroperative amino acid infusion thereby prevents the anaesthesia-induced reduction in metabolism and the accompanying postoperative hypothermia [15] . The present data confirm these findings and in addition suggest that amino acid infusion counteracts postoperative hypothermia when given, entirely or partly, before anaesthesia. The antihypothermic effect resulted from both increased preoperative heat accumulation and delayed metabolic stimulation immediately after anaesthesia. In addition, heat accumulation in response to amino acids infusion after premedication with lorazepam was greater than normal. Thus when started 1 h after lorazepam premedication, the amino acid infusion increased patients' rectal temperature by approximately 0.3 ЊC h
91
, an increase twice that observed in the volunteers subjected to identical amino acid infusions but not premedicated. This implies that premedication with lorazepam augmented selectively the accumulated part of the extra heat produced during amino acid administration. To our knowledge this response to lorazepam administration has not been reported before. In addition, patients receiving amino acid infusions for 2 h before anaesthesia or for 1 h before and 1 h of anaesthesia exhibited an increase in oxidative metabolism at awakening after anaesthesia of up to 50-60 % above baseline values (before anaesthesia). In the control patients, similarly premedicated and anaesthetized, but receiving saline instead of amino acids, energy expenditure did not increase significantly above baseline, despite vigorous shivering at awakening. Thus the ability of delayed metabolic stimulation, similar to that described recently at awakening immediately after peroperative amino acid infusions [15] , was demonstrable also at awakening 30-90 min after the end of amino acid infusions.
Shivering was observed in two of the patients receiving the 2-h amino acid infusion before anaesthesia, but in none of those who had received the infusion for 1 h before and 1 h of anaesthesia. This indicates that prevention of hypothermia was more effective when a peroperative period of infusion was included. This was illustrated further by the finding ) of amino acids in eight patients receiving amino acid infusion for 1 h before and 1 h of anaesthesia (A), in eight patients receiving amino acids for 2 h before anaesthesia (B), in eight control patients receiving saline solution (C) and in six female volunteers (D). Measurements at the end of amino acid infusion and 2 h later (mean (SEM)). *P < 0.05, **P < 0.01, ***P < 0.01 compared with values after the end of infusion that the initial decrease in temperature during the first 30 min of anaesthesia was prevented to a significantly greater extent, although not abolished, in patients receiving half of the infusion during anaesthesia. In those patients receiving the entire amino acid infusion before the onset of anaesthesia, the initial temperature change did not differ significantly from that in the control patients receiving saline. However, the considerable amounts of heat accumulated during the 2-h pre-anaesthesia amino acid infusion raised these patients' pre-anaesthesia temperatures to levels which prevented the temperature from reaching true hypothermic levels after operation. Thus the decrease in temperature during the initial phase of anaesthesia, probably reflecting redistribution of heat within the body [23, 24] , was not prevented by pre-anaesthetic infusions of amino acids, and prevented only partly in those patients in whom the infusions were continued during the first hour of anaesthesia. These results confirm our recent finding that peroperative amino acids could not significantly reduce the decrease in temperature until 20 min after the onset of anaesthesia [15] .
It is not immediately obvious why amino acidinduced heat accumulation should increase after premedication with lorazepam. Administration of benzodiazepines may interfere with central thermoregulatory control that normally limits the amino acid-induced upward regulation of the resting set point for arterial blood temperature [13] [14] [15] 25] . The finding of a significantly reduced resting energy expenditure in all patient groups 1 h after lorazepam is consistent with other reports of reduced metabolism after administration of benzodiazepines [26, 27] . However, the present data indicate that the thermic effect of amino acids was not quantitatively affected, although baseline energy expenditure was depressed by lorazepam.
At awakening, vigorous, generalized shivering occurred in all control patients not receiving amino acids. In spite of the shivering, oxygen consumption was not significantly higher than baseline levels. This finding, similar to that in our previous study [15] , confirms that, compared with delayed amino acid-induced thermogenesis, generalized shivering is a relatively weak stimulator of prompt increments in whole body oxidative metabolism in the early postoperative phase.
In awake volunteers, energy expenditure reached its maximum at the end of the 2-h amino acid infusion and then declined slowly. Heat accumulation, however, continued throughout the postinfusion observation period, maximum temperatures being recorded 60-90 min after the infusion. Thus the heat accumulation response to a 2-h amino acid infusion continued for a prolonged period, significant hyperthermia being evident for more than 2 h after the infusion. In patients receiving amino acids before or partly during anaesthesia, postoperative temperatures remained significantly higher than in the control patients during the entire postoperative observation period.
The present findings illustrate that the development of the postoperative hypothermia may be related to anaesthesia-induced suppression of heat production rather than increased heat elimination. The present results indicate that the mechanisms for increased thermogenesis and heat accumulation, when elicited by amino acids, are able to restart after an anaesthesia-induced intermission.
Pulmonary ventilation increased significantly on awakening from anaesthesia in the amino acid treated patients, but not in the control patients. As in our previous study [15] , oxygen saturation was normal, indicating that increased oxygen consumption was accompanied by a corresponding increase in ventilation.
In the premedicated patients but not in the volunteers, respiratory exchange ratio increased slightly during amino acid infusion. In male volunteers receiving similar amino acid infusions in earlier studies, the respiratory exchange ratio did not change [14] . It seems difficult to judge if this significant difference represents a true pharmacological effect of lorazepam.
Plasma amino acid concentrations were significantly lower in patients receiving the entire amino acid infusion before anaesthesia compared with those in whom the infusions continued during the first hour of anaesthesia. This might indicate that amino acids infused after the onset of anaesthesia are consumed by the tissues to a lesser extent than those infused before the onset of anaesthesia. However, the sum of the concentrations of all free amino acids was significantly lower also compared with that in volunteers. This might suggest that premedication per se could have increased tissue consumption of free amino acids, but additional studies are needed to elucidate this. A significant reduction in plasma concentrations of free amino acids during surgery has been described previously [28] .
Anaesthesia-induced postoperative hypothermia is a considerable clinical problem [29] and the present findings may have clinical potential. In suitable patients, i.v. infusion of an amino acid mixture before and during the beginning of anaesthesia for elective and acute surgery is an easy method of preventing anaesthesia-induced hypothermia. Furthermore, compared with the methods of treating hypothermia after operation [30, 31] , prevention with amino acids might be beneficial from a metabolic point of view. It has been shown that successful prevention of the development of anaesthesia-induced hypothermia with warming devices, combined with high operating room temperatures, also prevents negative nitrogen balance and catabolism in the postoperative period [3, 31] . Further studies are needed to establish if postoperative nitrogen balance is affected also when the development of postoperative hypothermia is prevented by means of amino acid administration.
The use of amino acids for prevention of anaesthesia-induced hypothermia cannot be recommended for all patients. Treatment should be limited strictly to those who can cope with the possible side effects of an amino acid load. It may be hazardous or harmful for patients with hepatic, renal or metabolic diseases, and should be avoided also in patients with cardiopulmonary insufficiency, who may be unable to cope with the enhanced demands for ventilation and gas transport that occur on awakening. In addition, it should of course be avoided in children :15 yr until tolerance studies have been performed. With these caveats, amino acid treatment might be a clinically useful and safe method for counteracting the development of anaesthesia-induced hypothermia and its postoperative complications.
